胞嘧啶市场规模、份额、趋势分析报告：按最终用途、按地区、细分市场预测，2024-2030 年

胞嘧啶市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球胞嘧啶市场规模将达到6.5481亿美元，预计2024年至2030年复合年增长率为9.6%。

这一增长归因于产品广泛应用于製药、农业和化学品等最终用途行业的各种应用。製药业是市场的主要最终用户。胞嘧啶是一种核苷酸碱基，用于合成各种药物，包括抗病毒药物、抗癌药物和核苷类似物。该行业对基因组学和个人化医疗的关注进一步增加了产品需求。

基因组研究需要分析DNA序列，而胞嘧啶则是构成DNA的四种核苷酸碱基之一。胞嘧啶在基因组序列测定和分析中发挥关键作用，对于阐明遗传变异和开发标靶治疗至关重要。全球工业提供了探索新应用并优化自身及其衍生物性能的研发机会。正在进行的研究可以集中在提高类似物的功效、生物有效性和安全性，从而改善爱滋病毒/爱滋病患者的治疗选择。此外，可以进行研究以探索应用于联合治疗和新的药物传输系统的可能性。对中间体产品的需求正在上升，特别是在个人化医疗和基因检测领域。

需求的增加可能会导致胞嘧啶价格上涨。由于该产品的多功能性和效用，以及对创新药物不断增长的需求，它被用于针对多种疾病和健康状况的药物开发的复杂过程中。农业部门主要围绕其他核苷酸碱基在农业应用中的利用。胞嘧啶在作物改良和育种计划中发挥重要作用。胞嘧啶和其他核苷酸碱基的遗传变异和突变对于传统作物育种至关重要，可以开发出具有抗病性、产量增加和营养成分增强等理想性状的改良作物品种。

胞嘧啶市场报告亮点

• 由于胞嘧啶在核酸疗法开发中的重要作用，药品将成为成长最快的最终用途领域，2024 年至 2030 年的复合年增长率为 9.8%。
• 由于製药和化学品等成熟的终端用户产业的存在，预计欧洲从 2024 年到 2030 年的复合年增长率将达到 10.3%。
• 胞嘧啶是植物基因体学和分子生物学研究的基本要素。植物科学家使用胞嘧啶和其他核苷酸碱基来研究植物基因的结构、功能和相互作用。
• 产品的消费受到各种政策的约束和必须遵循的政策。主要法规包括卫生和植物检疫措施（SPS）协议、智慧财产权（IPR）以及定价和报销政策。在某些情况下，这些法规和政策可能会阻碍产业发展。
• 围绕着产品的使用，尤其是针对各种疾病的药物合成，正在发生许多创新。
• 例如，2023 年 1 月，专门从事 DNA序列测定技术的英国公司 Cambridge 磊晶最近更名为 Biomodal。作为品牌重塑的一部分，该公司宣布推出新产品，提供简化的定序工作流程，可以捕捉 DNA 内的遗传和磊晶资讯。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 胞嘧啶：市场变数、趋势、范围

• 市场体系展望
  • 全球核苷酸市场展望
• 产业价值链分析
  • 原料趋势
  • 製造业趋势
  • 技术评估
  • 潜在最终用户列表
• 2023 年全球生产成本分析
• 成本结构分析，2023年（%）
• 法律规范（标准和合规性、核准、政策）
• 2018-2030年价格趋势分析
• 市场动态
  • 市场驱动因素分析
  • 市场抑制因素分析
  • 市场问题分析
  • 市场机会分析
• 产业分析工具
  • 波特的分析
  • 宏观经济分析PESTLE分析

第四章 胞嘧啶市场：最终用途估计与趋势分析

• 2023 年和 2030 年最终用途变化分析和市场占有率
  • 化学工业
  • 药品
  • 农业
  • 其他最终用途

第五章 胞嘧啶市场：区域估计与趋势分析

• 胞嘧啶市场：区域展望
• 北美洲
  • 2018-2030 年北美胞嘧啶市场估计与预测
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 2018-2030 年欧洲胞嘧啶市场估计与预测
  • 德国
  • 英国
  • 法国
• 亚太地区
  • 2018-2030 年亚太地区胞嘧啶市场估计与预测
  • 中国
  • 印度
  • 日本
• 中美洲和南美洲
  • 2018-2030 年拉丁美洲胞嘧啶市场估计与预测
• 中东和非洲
  • 中东和非洲胞嘧啶市场估计和预测，2018-2030

第六章竞争形势

• 公司分类
• 2023年公司市场定位分析
• 企业热力图分析
• 策略规划
• 公司名单（业务概况、财务表现、产品系列）
  • Spectrum Chemical
  • Tuoxin Pharmaceutical
  • VIVAN Life Sciences
  • KANTO KAGAKU
  • Tokyo Chemical Industry Co., Ltd.
  • SIELC Technologies
  • Santa Cruz Biotechnology, Inc.
  • FUJIFILM Wako Pure Chemical Corporation

Cytosine Market Growth & Trends:

The global cytosine market size is estimated to reach USD 654.81 million by 2030, and is expected to grow at a CAGR of 9.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to the extensive product usage in various applications in end-use industries, such as pharmaceuticals, agriculture, and chemicals. The pharmaceutical industry is a major end-user of the market. Cytosine is a nucleotide base, which is utilized in the synthesis of various pharmaceutical products, including antiviral drugs, anticancer agents, and nucleoside analogues. The emphasis on genomics and personalized medicine within the industry has further increased product demand.

Genomic research requires the analysis of DNA sequences, and it is one of the four nucleotide bases that make up DNA. Cytosine's role in genomic sequencing and analysis makes it indispensable for understanding genetic variations and developing targeted therapies. The global industry presents opportunities for R&D to explore new applications and optimize the properties of itself as well as its derivatives. Ongoing research can focus on enhancing the efficacy, bioavailability, and safety profiles of its analogs, leading to improved treatment options for HIV/AIDS patients. In addition, research can explore its potential use in combination therapies and novel drug delivery systems. The product demand as an intermediate has been on the rise, particularly in the field of personalized medicine and genetic testing.

This growing demand can contribute to upward pressure on the prices of cytosine. Versatile nature and utility of the product, as well as rising demand for innovative pharmaceuticals, has led to it being used in intricate processes in drug development directed toward varied ailments and health conditions. The agriculture segment primarily revolves around utilizing other nucleotide bases in agricultural applications. Cytosine plays a crucial role in crop improvement and breeding programs. Genetic variations and mutations in cytosine and other nucleotide bases are essential for traditional crop breeding, allowing the development of improved crop varieties with desirable traits, such as disease resistance, increased yield, and enhanced nutritional content.

Cytosine Market Report Highlights:

• Pharmaceuticals will emerge as the fastest-growing end-use segment with a CAGR of 9.8% from 2024 to 2030 due to cytosine's crucial role in the development of nucleic acid-based therapeutics
• Europe is expected to register the fastest CAGR of 10.3% from 2024 to 2030 due to the presence of well-established end-user industries, such as pharmaceuticals and chemicals
• Cytosine is a fundamental component in plant genomics and molecular biology research. Plant scientists utilize cytosine and other nucleotide bases to study the structure, function, and interactions of plant genes
• The product consumption is subjected to various policies/regulations that need to be followed. Some of the major regulations are Sanitary and Phytosanitary Measures (SPS) Agreement, Intellectual Property Rights (IPR), and Pricing and Reimbursement policies. In some cases, these policies/regulations pose a challenge to industry growth
• Numerous innovations are taking place that revolve around product usage, especially for the synthesis of drugs targeting various ailments
• For example, in January 2023, Cambridge Epigenetix, a UK-based company specializing in DNA sequencing technology, recently underwent rebranding and is now known as Biomodal. As a part of this rebranding, the company has launched a new product that offers a streamlined sequencing workflow capable of capturing both genetic & epigenetic information within DNA

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
• 1.2 Market Definition
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
• 1.4 Information analysis
• 1.5 Market formulation & data visualization
• 1.6 Data validation & publishing
  • 1.6.1 Research scope and assumptions
  • 1.6.2 List of Data Sources

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Cytosine: Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Global Nucleotide Market Outlook
• 3.2 Industry Value Chain Analysis
  • 3.2.1 Raw Material Trends
  • 3.2.2 Manufacturing Trends
  • 3.2.3 Technology Assessment
  • 3.2.4 List of Potential End-users
• 3.3 Global Production Cost Analysis, 2023 (USD/kg)
• 3.4 Cost Structure Analysis, 2023 (%)
• 3.5 Regulatory Framework (Standards and Compliances, Approvals, Policies)
• 3.6 Price Trend Analysis, 2018-2030 (USD/Kg)
• 3.7 Market Dynamics
  • 3.7.1 Market Driver Analysis
  • 3.7.2 Market Restraint Analysis
  • 3.7.3 Market Challenge Analysis
  • 3.7.4 Market Opportunities Analysis
• 3.8 Industry Analysis Tools
  • 3.6.1 PORTERs Analysis
  • 3.6.2 Macroeconomic Analysis- PESTLE Analysis

Chapter 4 Cytosine Market: End-use Estimates & Trend Analysis

• 4.1 End-use Movement Analysis & Market Share, 2023 & 2030
  • 4.1.1 Chemical Industry
  • 4.1.2 Pharmaceutical
  • 4.1.3 Agriculture
  • 4.1.4 Other End-uses

Chapter 5 Cytosine Market: Regional Estimates & Trend Analysis

• 5.1 Cytosine Market: Regional Outlook
• 5.2 North America
  • 5.2.1 North America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.2 U.S.
    • 5.2.2.1 Key Country Dynamics
    • 5.2.2.2 U.S. Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.3 Canada
    • 5.2.3.1 Key Country Dynamics
    • 5.2.3.2 Canada Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.4 Mexico
    • 5.2.4.1 Key Country Dynamics
    • 5.2.4.2 Mexico Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.3 Europe
  • 5.3.1 Europe Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.2 Germany
    • 5.3.2.1 Key Country Dynamics
    • 5.3.2.2 Germany Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.3 UK
    • 5.3.3.1 Key Country Dynamics
    • 5.3.3.2 UK Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.3 France
    • 5.3.3.1 Key Country Dynamics
    • 5.3.3.2 France Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.2 China
    • 5.4.2.1 Key Country Dynamics
    • 5.4.2.2 China Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.3 India
    • 5.4.3.1 Key Country Dynamics
    • 5.4.3.2 India Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.4 Japan
    • 5.4.4.1 Key Country Dynamics
    • 5.4.4.2 Japan Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.5 Central & South America
  • 5.5.1 Central & South America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)

Chapter 6 Competitive Landscape

• 6.1 Company Categorization
• 6.2 Company Market Positioning Analysis, 2023
• 6.3 Company Heat Map Analysis
• 6.4 Strategy Mapping
• 6.5 Company Listing (Business Overview, Financial Performance, Product Portfolio)
  • 6.5.1 Spectrum Chemical
  • 6.5.2 Tuoxin Pharmaceutical
  • 6.5.3 VIVAN Life Sciences
  • 6.5.4 KANTO KAGAKU
  • 6.5.5 Tokyo Chemical Industry Co., Ltd.
  • 6.5.6 SIELC Technologies
  • 6.5.7 Santa Cruz Biotechnology, Inc.
  • 6.5.8 FUJIFILM Wako Pure Chemical Corporation

List of Tables

• Table 1 List of Key Raw Material Suppliers
• Table 2 List of Potential End Users
• Table 3 U.S. macro-economic outlay
• Table 4 U.S. macro-economic outlay
• Table 5 Mexico macro-economic outlay
• Table 6 Germany macro-economic outlay
• Table 7 UK macro-economic outlay
• Table 8 France macro-economic outlay
• Table 9 China macro-economic outlay
• Table 10 India macro-economic outlay
• Table 11 Japan macro-economic outlay
• Table 12 Recent Developments & Impact Analysis, By Key Market Participants
• Table 13 Participant's Overview
• Table 14 Financial Performance
• Table 15 Company Heat Map Analysis

List of Figures

• Fig. 1 Cytosine Market Segmentation & Scope
• Fig. 2 Information procurement
• Fig. 3 Data analysis models
• Fig. 4 Market formulation and validation
• Fig. 5 Data validation & publishing
• Fig. 6 Cytosine Market Snapshot
• Fig. 7 Cytosine Market Segment Snapshot
• Fig. 8 Cytosine Market Competitive Landscape Snapshot
• Fig. 9 Global Nucleotides and Cytosine Market Value, 2023 (USD Million)
• Fig. 10 Cytosine Market: Industry Value Chain Analysis
• Fig. 11 Cytosine Market: Price Trend Analysis, 2018 - 2030 (USD/Kg)
• Fig. 12 Cytosine Market Dynamics
• Fig. 13 Cytosine Market: PORTERs Analysis
• Fig. 14 Cytosine Market: PESTLE Analysis
• Fig. 15 Cytosine Market Share, By End-use, 2023 & 2030
• Fig. 16 Cytosine Market Estimates & Forecasts, in Chemical Industry, 2018-2030 (Tons) (USD Thousand)
• Fig. 17 Cytosine Market Estimates & Forecasts, in Pharmaceuticals, 2018-2030 (Tons) (USD Thousand)
• Fig. 18 Cytosine Market Estimates & Forecasts, in Agriculture, 2018-2030 (Tons) (USD Thousand)
• Fig. 19 Cytosine Market Estimates & Forecasts, in Other End-uses, 2018-2030 (Tons) (USD Thousand)
• Fig. 20 Cytosine Market Revenue, by Region, 2023 & 2030 (USD Thousand)
• Fig. 21 North America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 22 U.S. Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 23 Canada Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 24 Mexico Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 25 Europe Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 26 Germany Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 27 UK Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 28 France Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 29 Asia Pacific Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 30 China Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 31 India Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 32 Japan Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 33 Central & South America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 34 Middle East & Africa Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 35 Key Company Categorization
• Fig. 36 Cytosine Market - Company Market Positioning Analysis - 2023
• Fig. 37 Strategic Mapping